Robuta

https://www.flexjobs.com/remote-jobs/company/emergent_biosolutions Emergent BioSolutions - Remote Work From Home Jobs & Careers | FlexJobs Find remote work from home jobs and careers with Emergent BioSolutions. Get a better remote job search with FlexJobs today! work from home jobsemergent biosolutionsremotecareersflexjobs https://www.globenewswire.com/news-release/2025/06/23/3103356/33240/en/Emergent-BioSolutions-Secures-62-4-Million-Contract-Modification-for-BAT-Botulism-Antitoxin-Heptavalent-A-B-C-D-E-F-G-Equine-to-Bolster-U-S-Biodefense-Supply.html Emergent BioSolutions Secures $62.4 Million Contract GAITHERSBURG, Md., June 23, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has been awarded a $62.4 million contract... emergent biosolutions4 millionsecures62contract https://www.oanda.com/eu-nl/trading/shares/us/emergent-biosolutions Emergent BioSolutions Inc (EBS) Handelen | Aandelen CFD's | OANDA Handel in aandelen van Emergent BioSolutions Inc (EBS) met OANDA. Bekijk live grafieken en de huidige marktrente voor dit aandeel. emergent biosolutions incebshandelenaandelencfd https://www.fool.com/earnings/call-transcripts/2021/07/30/emergent-biosolutions-inc-ebs-q2-2021-earnings-cal/ Emergent BioSolutions inc (EBS) Q2 2021 Earnings Call Transcript | The Motley Fool Jul 30, 2021 - EBS earnings call for the period ending June 30, 2021. emergent biosolutions incearnings call transcript https://informaconnect.com/pharmaceutical-compliance-congress-pcc/speakers/joseph-philipose/ Joseph Philipose - Emergent BioSolutions | Pharmaceutical Compliance Congress (PCC) 2026 Speaker Join the Pharmaceutical Compliance Congress (PCC) 2026 - the leading life sciences compliance event with expert insights, enforcement trends, strategic... emergent biosolutionsjosephphiliposepharmaceuticalcompliance https://www.jnj.com/media-center/press-releases/johnson-johnson-statement-on-fda-observations-at-emergent-biosolutions Johnson & Johnson Statement on FDA Observations at Emergent BioSolutions (Updated 4/30) emergent biosolutionsjohnsonstatementfdaobservations https://www.globenewswire.com/de/news-release/2026/03/03/3248278/33240/en/Emergent-BioSolutions-Announces-Appointment-of-John-D-Fowler-Jr-to-Board-of-Directors.html Emergent BioSolutions Announces Appointment of John D. GAITHERSBURG, Md., March 03, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced the appointment of John D. Fowler, Jr. to... emergent biosolutionsannouncesappointmentjohn https://www.home.saxo/fr-fr/markets/stocks/ebs-xnys Emergent BioSolutions Inc. action | Saxo Banque Emergent BioSolutions Inc offers public health products to the government and healthcare providers. emergent biosolutions incactionsaxobanque https://theorg.com/org/emergent-biosolutions?person=liz-petrone Emergent BioSolutions | The Org Emergent BioSolutions is a multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland, USA. emergent biosolutions https://www.macrotrends.net/stocks/charts/EBS/emergent-biosolutions/cash-flow-statement Emergent Biosolutions Cash Flow Statement 2011-2026 | EBS | MacroTrends Ten years of annual cash flow statements for Emergent Biosolutions (EBS). The cash flow statement is a summary of the cash inflows and outflows for a business... cash flow statementemergent biosolutions20112026ebs https://www.home.saxo/da-dk/markets/stocks/ebs-xnys Emergent BioSolutions Inc. aktie | Saxo Emergent BioSolutions Inc offers public health products to the government and healthcare providers. emergent biosolutions incaktiesaxo https://www.fool.com/earnings/call-transcripts/2022/04/29/emergent-biosolutions-ebs-q1-2022-earnings-call-tr/ Emergent BioSolutions (EBS) Q1 2022 Earnings Call Transcript | The Motley Fool Apr 29, 2022 - EBS earnings call for the period ending March 31, 2022. earnings call transcriptemergent biosolutionsthe motleyebsq1 https://www.fool.com/investing/2022/05/23/why-emergent-biosolutions-stock-is-jumping-today/ Why Emergent BioSolutions Stock Is Jumping Today | The Motley Fool May 23, 2022 - Monkeypox concerns are boosting the stock. why emergentthe motleybiosolutionsstockjumping https://www.nasdaq.com/market-activity/stocks/ebs Emergent BioSolutions Inc. Common Stock (EBS) Stock Price, Quote, News & History | Nasdaq Discover real-time Emergent BioSolutions Inc. Common Stock (EBS) stock prices, quotes, historical data, news, and Insights for informed trading and investment... emergent biosolutions inccommon stockprice quotenews history https://www.fool.com/investing/2021/04/13/why-emergent-biosolutions-stock-fell-today/ Why Emergent BioSolutions Stock Fell Today | The Motley Fool why emergentthe motleybiosolutionsstockfell https://www.salon.com/topic/emergent-biosolutions?utm-source=website&utm-medium=social&utm-campaign=ogshare&utm-content=og Emergent BioSolutions Archives - Salon.com "Stock prices were inflated by billions the Trump Administration shoveled into drug company coffers," watchdog says. emergent biosolutionsarchivessalon https://www.macrotrends.net/stocks/charts/EBS/emergent-biosolutions/pre-tax-profit-margin Emergent Biosolutions Pre-Tax Profit Margin 2012-2026 | EBS | MacroTrends Emergent Biosolutions pre-tax profit margin from 2012 to 2026. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. pre tax profitemergent biosolutionsmargin20122026 https://theorg.com/org/emergent-biosolutions?person=jenny-bryan Emergent BioSolutions | The Org Emergent BioSolutions is a multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland, USA. emergent biosolutions https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-ebs/emergent-biosolutions Emergent BioSolutions (NYSE:EBS) - Stock Analysis - Simply Wall St Research Emergent BioSolutions' (NYSE:EBS) fundamentals, past performance, valuation, dividends and more. emergent biosolutionsstock analysisnyseebssimply https://www.macrotrends.net/stocks/charts/EBS/emergent-biosolutions/balance-sheet Emergent Biosolutions Balance Sheet 2011-2026 | EBS | MacroTrends Ten years of annual and quarterly balance sheets for Emergent Biosolutions (EBS). The balance sheet is a financial report that shows the assets of a business... emergent biosolutionsbalance sheet20112026ebs https://www.fool.com/investing/2023/06/27/why-emergent-biosolutions-stock-dived-by-9-today/ Why Emergent BioSolutions Stock Dived by 9% Today | The Motley Fool Jun 27, 2023 - Investors didn't greet news of the CEO's departure warmly. why emergentthe motleybiosolutionsstockdived https://www.annualreports.com/Company/emergent-biosolutions-inc Emergent BioSolutions, Inc. - AnnualReports.com emergent biosolutions inc https://www.fool.com/investing/2020/03/10/heres-why-emergent-biosolutions-jumped-higher-on-t.aspx Here's Why Emergent BioSolutions Jumped Higher on Tuesday | The Motley Fool Mar 10, 2020 - The company added its name to the long list of companies helping develop a vaccine to the coronavirus that causes COVID-19. here swhy emergent https://www.upguard.com/security-report/emergentbiosolutions Emergent BioSolutions Security Rating, Vendor Risk Report, and Data Breaches | UpGuard Compare Emergent BioSolutions's security performance with other companies. Learn about data breaches, cyber attacks, and security incidents involving Emergent... emergent biosolutionssecurity ratingvendor riskdata breaches https://www.terrapinn.com/conference/world-vaccine-immunotherapy-congress-west-coast/sponsor-emergent-biosolutions.stm Emergent BioSolutions, sponsor of | Vaccine West Coast emergent biosolutionssponsor ofvaccinewestcoast https://www.salon.com/topic/emergent-biosolutions Emergent BioSolutions Archives - Salon.com "Stock prices were inflated by billions the Trump Administration shoveled into drug company coffers," watchdog says. emergent biosolutionsarchivessalon https://www.cbsnews.com/baltimore/news/additional-135-million-doses-of-emergent-biosolutions-made-covid-vaccines-rejected-panel-says/ Additional 135 million doses of Emergent BioSolutions-made COVID vaccines rejected, panel says -... https://www.fool.com/investing/2020/06/03/emergent-biosolutions-picks-up-a-warp-speed-contra.aspx Emergent BioSolutions Picks Up a "Warp Speed" Contract to Manufacture Coronavirus Vaccines | The... Jun 3, 2020 - The contract development and manufacturing organization will support a number of SARS-CoV-2 vaccine candidates. https://www.democracynow.org/2021/5/20/headlines/emergent_biosolutions_reaped_millions_in_federal_contracts_but_has_yet_to_deliver_any_covid_vaccines Emergent BioSolutions Reaped Millions in Federal Contracts But Has Yet to Deliver Any COVID... Executives from biotech company Emergent BioSolutions were grilled by lawmakers Wednesday over multiple failures in their manufacturing of coronavirus... https://www.fiercebiotech.com/biotech/vaxgen-sells-anthrax-vaccine-program-and-related-assets-and-technology-to-emergent VaxGen Sells Anthrax Vaccine Program and Related Assets and Technology to Emergent BioSolutions |... May 5, 2008 - VaxGen Sells Anthrax Vaccine Program and Related Assets and Technology to Emergent BioSolutions SOUTH SAN FRANCISCO, Calif., May 5 -- VaxGen, Inc., a... anthrax vaccine https://www.benzinga.com/trading-ideas/movers/23/07/33481513/12-health-care-stocks-moving-in-mondays-after-market-session 12 Health Care Stocks Moving In Monday's After-Market Session - Emergent BioSolutions (NYSE:EBS),... https://www.cbsnews.com/baltimore/news/emergent-biosolutions-gearing-up-to-mass-produce-future-covid-19-vaccine/ Emergent BioSolutions Gearing Up To Mass-Produce Future COVID-19 Vaccine - CBS Baltimore A Baltimore-based company is gearing up to mass-produce a COVID-19 vaccine once it's approved. https://www.biospace.com/emergent-biosolutions-to-invest-75-million-in-canton-site-and-expand-viral-vector-and-gene-therapy-capability Emergent BioSolutions to Invest $75 Million in Canton Site and Expand Viral Vector and Gene Therapy... Jun 18, 2020 - Emergent BioSolutions announced that it will further strengthen its contract development and manufacturing capabilities by expanding into viral vector and gene... https://www.canada.ca/en/health-canada/news/2021/06/update-on-janssen-covid-19-vaccines-made-with-drug-substance-from-emergent-biosolutions.html Update on Janssen COVID-19 vaccines made with drug substance from Emergent BioSolutions - Canada.ca Health Canada has completed its quality review of the shipment of Janssen vaccines that are currently in quarantine. https://www.cbsnews.com/baltimore/news/fda-preparing-to-clear-10m-johnson-johnson-covid-vaccine-doses-from-baltimores-emergent-biosolutions/ FDA Clears 10M Johnson & Johnson COVID Vaccine Doses From Baltimore's Emergent BioSolutions - CBS...